Gf Fund Management Co. Ltd. Arcellx, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Arcellx, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,384 shares of ACLX stock, worth $87,192. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,384
Previous 1,135
21.94%
Holding current value
$87,192
Previous $87 Million
4.3%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACLX
# of Institutions
214Shares Held
48.8MCall Options Held
764KPut Options Held
296K-
Paradigm Biocapital Advisors LP New York, NY4.49MShares$283 Million15.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.99MShares$251 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$236 Million23.3% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$222 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.04MShares$191 Million4.14% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.76B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...